Filgrastim Recruiting Phase 1 Trials for Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome / Recurrent Plasma Cell Myeloma / Aplastic Anaemia (AA) / Recurrent Small Lymphocytic Lymphoma / Leukemias / Plasma Cell Myeloma / chronic, recurrent Lymphocytic Leukemia / Acute myeloid leukaemia (in remission) / Therapy-Related Myelodysplastic Syndrome / Blasts Under 10 Percent of Bone Marrow Nucleated Cells / Minimal Residual Disease / Adult Acute Lymphoblastic Leukemia in Complete Remission / Recurrent Non-Hodgkin Lymphoma / Chronic Myelomonocytic Leukemia / Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Myeloproliferative Neoplasms / Hematopoietic Cell Transplantation Recipient / Recurrent Hodgkin Lymphoma Treatment